Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 21, Pages 6452
Publisher
MDPI AG
Online
2021-10-27
DOI
10.3390/molecules26216452
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells
- (2021) Dinisha Kamble et al. Cells
- SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma
- (2021) Alessandro Allegra et al. CLINICAL BIOCHEMISTRY
- Mechanisms of cancer stem cell senescence: Current understanding and future perspectives
- (2021) Da‐Yong Zhang et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- A review of the racial heterogeneity of breast cancer stem cells
- (2021) Eric Gyan et al. GENE
- Cancer stem cells targets and combined therapies to prevent cancer recurrence
- (2021) Pawan Kumar Raghav et al. LIFE SCIENCES
- Luteolin induces mitochondrial apoptosis in HT29 cells by inhibiting the Nrf2/ARE signaling pathway
- (2020) Huan Yang et al. Experimental and Therapeutic Medicine
- The Function and Prognostic Significance of Cripto-1 in Colorectal Cancer
- (2020) Jun Sato et al. CANCER INVESTIGATION
- Targeted drug therapy to overcome chemoresistance in Triple Negative Breast Cancer
- (2020) Mamta Kumari et al. CURRENT CANCER DRUG TARGETS
- Expression of Nrf2 and NF-κB transcription factors in breast cancer and breast fibroadenoma: Insights for a new therapeutic approach
- (2020) Camila Maria Simplicio-Revoredo et al. Oncotarget
- Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer
- (2020) Chunhua Xu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance
- (2020) Zahra Payandeh et al. BIOCHIMIE
- Interplay between TRAP1 and sirtuin-3 modulates mitochondrial respiration and oxidative stress to maintain stemness of glioma stem cells
- (2019) Hye-Kyung Park et al. CANCER RESEARCH
- Luteolin, a flavonoid, as an anticancer agent: A review
- (2019) Muhammad Imran et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects
- (2019) Anoop K. Yadav et al. Stem Cell Reviews and Reports
- Brusatol, an NRF2 inhibitor for future cancer therapeutic
- (2019) Sabrina J. Cai et al. Cell and Bioscience
- Nrf2-induced reductive stress favours self-renewal of breast cancer stem-like cells via the FoxO3a-Bmi-1 axis
- (2019) Do-Hee Kim et al. ANTIOXIDANTS & REDOX SIGNALING
- The prognostic value of NRF2 in breast cancer patients: a systematic review with meta-analysis
- (2019) Micaela Almeida et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibition of aldehyde dehydrogenase-1 and p-glycoprotein-mediated multidrug resistance by curcumin and vitamin D3 increases sensitivity to paclitaxel in breast cancer
- (2019) Yasmeen M. Attia et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The Role of Nrf2 signaling in cancer stem cells: From stemness and self-renewal to tumorigenesis and chemoresistance
- (2019) Houman Kahroba et al. LIFE SCIENCES
- Cancer stem cell in breast cancer therapeutic resistance
- (2018) Xupeng Bai et al. CANCER TREATMENT REVIEWS
- Selective Cytotoxicity of Luteolin and Kaempferol on Cancerous Hepatocytes Obtained from Rat Model of Hepatocellular Carcinoma: Involvement of ROS-Mediated Mitochondrial Targeting
- (2018) Enayatollah Seydi et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling
- (2018) Donghyeok Kim et al. Cell Death & Disease
- Cripto-1 plasmid DNA vaccination targets metastasis and cancer stem cells in murine mammary carcinoma
- (2018) Kristina Witt et al. Cancer Immunology Research
- Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses
- (2018) Li Li et al. PHYTOMEDICINE
- The expression of the embryonic gene Cripto-1 is regulated by OCT4 in human embryonal carcinoma NCCIT cells
- (2017) Sung-Won Park et al. FEBS LETTERS
- Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma
- (2017) Qiang Liu et al. Molecular Cancer
- Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer
- (2016) Maria Cristina Rangel et al. BREAST CANCER RESEARCH AND TREATMENT
- Luteolin induces cholangiocarcinoma cell apoptosis through the mitochondrial-dependent pathway mediated by reactive oxygen species
- (2016) Natthawan Kittiratphatthana et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance
- (2016) A. L. Furfaro et al. Oxidative Medicine and Cellular Longevity
- Cripto-1 in TNBC
- (2015) Nadia P Castro et al. Aging-US
- Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells
- (2015) Ilaria Dando et al. Oxidative Medicine and Cellular Longevity
- Cripto-1 as a novel therapeutic target for triple negative breast cancer
- (2015) Nadia P. Castro et al. Oncotarget
- Luteolin Sensitizes Two Oxaliplatin-Resistant Colorectal Cancer Cell Lines to Chemotherapeutic Drugs Via Inhibition of the Nrf2 Pathway
- (2014) Song Chian et al. Asian Pacific Journal of Cancer Prevention
- Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo
- (2014) Song Chian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulation of MnSOD Enzymatic Activity by Sirt3 Connects the Mitochondrial Acetylome Signaling Networks to Aging and Carcinogenesis
- (2013) Randa Tao et al. ANTIOXIDANTS & REDOX SIGNALING
- The significance of a Cripto-1-positive subpopulation of human melanoma cells exhibiting stem cell-like characteristics
- (2013) Luigi Strizzi et al. CELL CYCLE
- NRF2 immunolocalization in human breast cancer patients as a prognostic factor
- (2013) Yoshiaki Onodera et al. ENDOCRINE-RELATED CANCER
- Role of Cripto-1 during Epithelial-to-Mesenchymal Transition in Development and Cancer
- (2012) Maria C. Rangel et al. AMERICAN JOURNAL OF PATHOLOGY
- Cancer Stem Cells and Novel Targets for Antitumor Strategies
- (2012) Gerald J. Prud’homme CURRENT PHARMACEUTICAL DESIGN
- Cancer stem cells and metastasis
- (2012) Katia Sampieri et al. SEMINARS IN CANCER BIOLOGY
- Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs
- (2011) Xiuwen Tang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Role of Cripto-1 in Stem Cell Maintenance and Malignant Progression
- (2010) Caterina Bianco et al. AMERICAN JOURNAL OF PATHOLOGY
- In vitro and in vivo hepatoprotective effects of the aqueous extract from Taraxacum officinale (dandelion) root against alcohol-induced oxidative stress
- (2010) Yanghee You et al. FOOD AND CHEMICAL TOXICOLOGY
- Reactive oxygen species in cancer
- (2010) Geou-Yarh Liou et al. FREE RADICAL RESEARCH
- Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
- (2008) Yong Lin et al. CURRENT CANCER DRUG TARGETS
- Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer
- (2008) X-Y Zhong et al. HISTOPATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search